Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

High-Risk Multiple Myeloma in Benefit (IFM 2020-05) Phase 3 Randomized Study of Isatuximab (Isa) Plus Lenalidomide and Dexamethasone (Rd) with Bortezomib Versus Isard in Patients with Newly Diagnosed Transplant Ineligible Multiple Myeloma (NDMM TI)

Jill Corre, Jérôme Lambert, Arthur Bobin, Salomon Manier, Aurore Perrot, Lionel Karlin, Murielle Roussel, Noemie Bigot, Omar Benbrahim, Olivier Thierry Allangba, Philippe Rey, Veronique Dorvaux, Marguerite Vignon, Virginie Roland, Reda Garidi, Jean-Noel Bastie, Marie-Lorraine Chrétien, Sophie Godet, Lydia Montes, Brieuc Cherel, Thomas Chalopin, Borhane Slama, Kamel Laribi, Claire Dingremont, Christophe Roul, Valentine Richez, Clara Mariette, Sophie Rigaudeau, Claire Calmettes, Mamoun Dib, Mourad Tiab, Laure Vincent, Jacques Delaunay, Jean Pierre Marolleau, Pascal Godmer, Laurent Frenzel, Ronan Le Calloch, Emilie Chalayer, Helene Gardeney, Margaret Macro, Bruno Royer, Olivier Decaux, Bertrand Arnulf, Karim Belhadj Merzoug, Cyrille Touzeau, Mohamad Mohty, Aurelie Gontier, Amine Kasmi, Philippe Moreau, Thierry Facon, Herve Avet Loiseau, Cyrille Hulin, Xavier Leleu

Blood (2024) 144 (Supplement 1): 4756.

https://doi.org/10.1182/blood-2024-210345

Published: 2024

Journal Articles

Somatic Mutation Profile Analyzed By Next-Generation Sequencing in Relapsed/Refractory Follicular Lymphoma Treated with Idelalisib

Blood (2019) 134 (Supplement_1): 1503.

https://doi.org/10.1182/blood-2019-126459

Published: 2019

Journal Articles

A New Simplified Prognostic Index Integrating the Type of Extra-Nodal Involvement and Age for Ann Arbor Stage IV Hodgkin Lymphoma Patients Diagnosed at TEP-Scanner Era: A Retrospective Analysis from Lymphoma Study Association (LYSA) Centers

Blood (2018) 132 (Supplement 1): 1629.

https://doi.org/10.1182/blood-2018-99-118578

Published: 2018

Journal Articles

The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia

Blood (2016) 127 (17): 2157–2160.

https://doi.org/10.1182/blood-2016-01-689976

Published: 2016

Includes: Supplemental data

Journal Articles

Comparison Of Hevylite™ Assay and Plasma Cell Immunophenotyping For Response Evaluation and Residual Disease Characterisation In IgA Myeloma

Daniela Lakomy, Stephanie Lemaire-Ewing, Cedric Rossi, Jessica Borgeot, Jean-Noël Bastie, Ingrid Lafon, Marc Maynadie, Denis Caillot, MD, Julien Guy

Blood (2013) 122 (21): 5319.

https://doi.org/10.1182/blood.V122.21.5319.5319

Published: 2013

Journal Articles

Prognostic Factors Of Response and Survival To Azacitidine (AZA) +/- EPO In RBC Transfusion Dependent (TD) IPSS Low and Int-1 (LR) MDS Resistant To EPO, With Particular Emphasis Of Genetic Lesions: A Study By The GFM

Blood (2013) 122 (21): 658.

https://doi.org/10.1182/blood.V122.21.658.658

Published: 2013

Journal Articles

Interim [18F]Fluorodeoxyglucosepositron Emission Tomography Suvmax Reduction Is Superior to Visual Analysis to Predict Early patient's Outcome in Hodgkin Lymphoma

Cedric Rossi, MD, Salim Kanoun, MD, Alina Berriolo-Riedinger, MD, Olivier Humbert, MD, Inna Dygay-Cochet, MD, Caroline Legouge, MD, Marie-Lorraine Chretien, M.D, Louis Berthet, MD, Jean-Noel Bastie, MD, PhD, Rene-Olivier Casasnovas, MD

Blood (2012) 120 (21): 3630.

https://doi.org/10.1182/blood.V120.21.3630.3630

Published: 2012

Journal Articles

Metabolic Tumor Volume Is an Independent Prognosis Factor Predicting patient's Outcome in Hodgkin Lymphoma

Salim Kanoun, MD, Cedric Rossi, MD, Alina Berriolo-Riedinger, MD, Olivier Humbert, MD, Inna Dygay-Cochet, MD, Marie-Lorraine Chretien, M.D, Caroline Legouge, MD, Louis Berthet, MD, Jean-Noel Bastie, MD, PhD, Rene-Olivier Casasnovas, MD

Blood (2012) 120 (21): 3631.

https://doi.org/10.1182/blood.V120.21.3631.3631

Published: 2012

Journal Articles

A MiR-142-3p/EGR2 Feedback Circuitry In Human CSF-1 Driven Differentiation of Monocytes Into Macrophages

Brice Lagrange, PhD, Nathalie Droin, Ph.D, Romain Aucagne, PhD, Jérôme Paggetti, PhD, Anne Largeot, Eric Solary, MD., Ph.D, Laurent Delva, PhD, Jean-Noel Bastie, MD, PhD

Blood (2011) 118 (21): 2366.

https://doi.org/10.1182/blood.V118.21.2366.2366

Published: 2011

Journal Articles

Fractionated Doses of Gemtuzumab Ozogamicin (GO) Combined to Standard Chemotherapy (CT) Improve Event-Free and Overall Survival in Newly-Diagnosed De Novo AML Patients Aged 50–70 Years Old: A Prospective Randomized Phase 3 Trial From the Acute Leukemia French Association (ALFA)

Blood (2011) 118 (21): 6.

https://doi.org/10.1182/blood.V118.21.6.6

Published: 2011

Journal Articles

Distinct Expression Patterns of microRNAs in Activated B Cell (ABC) and Germinal Center B (GC) Subtypes of Diffuse Large B Cell Lymphoma (DLBLC).

Jean-Noel Bastie, Jean-Philippe Jais, Thierry Molina, Emmanuelle Come, Bertrand Coiffier, Christian Gisselbrecht, David Rickman, Aurelien de Reynies, Josette Briere, Philippe Gaulard, Pierre Feugier, Herve Tilly, Gilles Salles, Corinne Haioun, Karen Leroy

Blood (2007) 110 (11): 562.

https://doi.org/10.1182/blood.V110.11.562.562

Published: 2007

Journal Articles

Cooperative Action of 1alpha,25-Dihydroxyvitamin D3 and Retinoic Acid in NB4 Acute Promyelocytic Leukemia Cell Differentiation Is Transcriptionally Controlled.

Jean-Noel Bastie, MD, PhD, Nicole Balitrand, Isabelle Guillemot, Christine Chomienne, MD, PhD, Laurent Delva, PhD

Blood (2005) 106 (11): 4247.

https://doi.org/10.1182/blood.V106.11.4247.4247

Published: 2005

NARROW

High-Risk Multiple Myeloma in Benefit (IFM 2020-05) Phase 3 Randomized Study of Isatuximab (Isa) Plus Lenalidomide and Dexamethasone (Rd) with Bortezomib Versus Isard in Patients with Newly Diagnosed Transplant Ineligible Multiple Myeloma (NDMM TI)

Somatic Mutation Profile Analyzed By Next-Generation Sequencing in Relapsed/Refractory Follicular Lymphoma Treated with Idelalisib

A New Simplified Prognostic Index Integrating the Type of Extra-Nodal Involvement and Age for Ann Arbor Stage IV Hodgkin Lymphoma Patients Diagnosed at TEP-Scanner Era: A Retrospective Analysis from Lymphoma Study Association (LYSA) Centers

The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia

Comparison Of Hevylite™ Assay and Plasma Cell Immunophenotyping For Response Evaluation and Residual Disease Characterisation In IgA Myeloma

Prognostic Factors Of Response and Survival To Azacitidine (AZA) +/- EPO In RBC Transfusion Dependent (TD) IPSS Low and Int-1 (LR) MDS Resistant To EPO, With Particular Emphasis Of Genetic Lesions: A Study By The GFM

Interim [18F]Fluorodeoxyglucosepositron Emission Tomography Suvmax Reduction Is Superior to Visual Analysis to Predict Early patient's Outcome in Hodgkin Lymphoma

Metabolic Tumor Volume Is an Independent Prognosis Factor Predicting patient's Outcome in Hodgkin Lymphoma

A MiR-142-3p/EGR2 Feedback Circuitry In Human CSF-1 Driven Differentiation of Monocytes Into Macrophages

Fractionated Doses of Gemtuzumab Ozogamicin (GO) Combined to Standard Chemotherapy (CT) Improve Event-Free and Overall Survival in Newly-Diagnosed De Novo AML Patients Aged 50–70 Years Old: A Prospective Randomized Phase 3 Trial From the Acute Leukemia French Association (ALFA)

Distinct Expression Patterns of microRNAs in Activated B Cell (ABC) and Germinal Center B (GC) Subtypes of Diffuse Large B Cell Lymphoma (DLBLC).

Cooperative Action of 1alpha,25-Dihydroxyvitamin D3 and Retinoic Acid in NB4 Acute Promyelocytic Leukemia Cell Differentiation Is Transcriptionally Controlled.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only